What is the current stock price of Manzo Pharmaceuticals, Inc. (MNZO)?

As of the latest market data, Manzo Pharmaceuticals, Inc. (MNZO) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Manzo Pharmaceuticals, Inc. (MNZO) pay a dividend?

Based on current data, Manzo Pharmaceuticals, Inc. does not have a confirmed active dividend policy.

What is the market cap of Manzo Pharmaceuticals, Inc.?

The current market capitalization of Manzo Pharmaceuticals, Inc. (MNZO) is approximately unavailable.

MNZO

Manzo Pharmaceuticals, Inc.·Financial Services

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.

Sector

Financial Services

Industry

Shell Companies

Employees

IPO Date

1998-12-31

Beta

-44.70

Websitewww.lactofreedom.com↗